000 01543 a2200421 4500
005 20250517041305.0
264 0 _c20151106
008 201511s 0 0 eng d
022 _a1532-1967
024 7 _a10.1016/j.ctrv.2015.06.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPetrulea, Mirela S
245 0 0 _aPI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinoma.
_h[electronic resource]
260 _bCancer treatment reviews
_cSep 2015
300 _a707-13 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aCarcinogenesis
_xdrug effects
650 0 4 _aCarcinoma
_xdrug therapy
650 0 4 _aCarcinoma, Papillary
650 0 4 _aDisease Management
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aMutation
650 0 4 _aNuclear Proteins
_xgenetics
650 0 4 _aProto-Oncogene Proteins c-akt
_xgenetics
650 0 4 _aSignal Transduction
_xgenetics
650 0 4 _aTOR Serine-Threonine Kinases
_xgenetics
650 0 4 _aThyroid Cancer, Papillary
650 0 4 _aThyroid Neoplasms
_xdrug therapy
650 0 4 _aTranscription Factors
_xgenetics
700 1 _aPlantinga, Theo S
700 1 _aSmit, Jan W
700 1 _aGeorgescu, Carmen E
700 1 _aNetea-Maier, Romana T
773 0 _tCancer treatment reviews
_gvol. 41
_gno. 8
_gp. 707-13
856 4 0 _uhttps://doi.org/10.1016/j.ctrv.2015.06.005
_zAvailable from publisher's website
999 _c25040768
_d25040768